Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia
NCT05229484 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62
Last updated 2022-04-15
Summary
Total cholesterol levels and other lipids are associated with violence in psychiatric patients. There is a paucity of studies on preventive interventions. In this study, an integrated multimodal lifestyle intervention (MLifeI) for management of repetitive violence in schizophrenia is proposed. A controlled clinical trial was carried out to evaluate the effects of MLifeI on management of repetitive violence through regulation of serum lipids, TC in particular, to the recommended levels in schizophrenia. The investigators examined whether the MLifeI could: 1. regulate or balance lipid profiles; 2. reduce violence risk; 3. improve impulsivity; and 4. improve general cognitive functioning.
Conditions
Interventions
- OTHER
-
an integrated multimodal lifestyle intervention (MLifeI)
The MLifeI program focused on the roles of health responsibility, review of lipid profile, complications of imbalanced lipid profile, lipid management and nutritional education.
Sponsors & Collaborators
-
I-Shou University
lead OTHER
Principal Investigators
-
Mei-Chi Hsu, Ph.D · I-Shou University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-15
- Primary Completion
- 2018-08-14
- Completion
- 2018-08-14
Countries
- Taiwan
Study Locations
More Related Trials
-
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
NCT04917302 ·Status: RECRUITING ·Phase: PHASE2
-
Trial and Follow-up of the Efficacy of Two-stage Integrated Treatment for Chinese Schizophrenia Inpatients
NCT02850445 ·Status: UNKNOWN ·Phase: NA
-
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
NCT05240976 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia
NCT03667729 ·Status: COMPLETED ·Phase: NA
-
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
NCT07122895 ·Status: RECRUITING ·Phase: PHASE2
-
Mindfulness-based Illness Management Program for Schizophrenia
NCT01667601 ·Status: COMPLETED ·Phase: NA
-
The Establishment of the Early Intervention Program for Patients With Schizophrenia
NCT00172770 ·Status: UNKNOWN
-
Antipsychotic Effects of Probiotics and Prebiotics on Patients With Schizophrenia
NCT04291469 ·Status: UNKNOWN ·Phase: NA
-
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201 ·Status: RECRUITING ·Phase: PHASE2
-
Exploring the Effect of Rumination-Focused Cognitive Behaviour Therapy in Patients With Schizophrenia
NCT04442893 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
NCT00063297 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism
NCT02552758 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia
NCT00338832 ·Status: COMPLETED ·Phase: PHASE3
-
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder
NCT04022577 ·Status: COMPLETED ·Phase: NA
-
Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.
NCT07148609 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Theory Based Integrated Program on Medication Adherence Among Community Dwelling Schizophrenia
NCT05835583 ·Status: COMPLETED ·Phase: NA
-
Peer-led Psycho-education for Schizophrenia
NCT03246932 ·Status: COMPLETED ·Phase: NA
-
Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer
NCT05052853 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia
NCT03434210 ·Status: UNKNOWN ·Phase: NA
-
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial
NCT06838104 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
NCT03663465 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Preliminary Effect of Baduanjin Program for People Diagnosed With Schizophrenia
NCT04027634 ·Status: COMPLETED ·Phase: NA
-
Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.
NCT04916483 ·Status: UNKNOWN ·Phase: NA
-
Interventional Programs' Impact on Patients' Quality of Life and Functioning
NCT06715553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA